VNET Group Q2 Revenue Jumps 22 Percent, Wholesale Capacity Grows 17.5% QoQ

Castle Biosciences will participate in three investor conferences in September 2025, including a presentation at Baird's 2025 Global Healthcare Conference on September 10. The company's management team will also be available for one-on-one meetings at the Wells Fargo and Lake Street investor conferences. Investors can coordinate meetings through Wells Fargo and Lake Street Capital Markets, respectively. Castle Biosciences is a leading healthcare diagnostics company with a focus on skin cancers, Barrett's esophagus, and uveal melanoma.